Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Hepatolenticular Degeneration HELP
Based on 1,526 articles published since 2010
||||

These are the 1526 published articles about Hepatolenticular Degeneration that originated from Worldwide during 2010-2020.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline American Gastroenterological Association Institute Guidelines for the Diagnosis and Management of Acute Liver Failure. 2017

Flamm, Steven L / Yang, Yu-Xiao / Singh, Siddharth / Falck-Ytter, Yngve T / Anonymous4340892. ·Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois. · Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Division of Gastroenterology, University of California San Diego, La Jolla, California. · Division of Gastroenterology, Cleveland VA Medical Center and University Hospitals, Case Western Reserve University, Cleveland, Ohio. ·Gastroenterology · Pubmed #28056348.

ABSTRACT: -- No abstract --

2 Guideline ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. 2017

Kwo, Paul Y / Cohen, Stanley M / Lim, Joseph K. ·Division of Gastroenterology/Hepatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA. · Digestive Health Institute, University Hospitals Cleveland Medical Center and Division of Gastroenterology and Liver Disease, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. · Yale Viral Hepatitis Program, Yale University School of Medicine, New Haven, Connecticut, USA. ·Am J Gastroenterol · Pubmed #27995906.

ABSTRACT: Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is defined as disproportionate elevation of alkaline phosphatase level as compared with AST and ALT levels. The majority of bilirubin circulates as unconjugated bilirubin and an elevated conjugated bilirubin implies hepatocellular disease or cholestasis. Multiple studies have demonstrated that the presence of an elevated ALT has been associated with increased liver-related mortality. A true healthy normal ALT level ranges from 29 to 33 IU/l for males, 19 to 25 IU/l for females and levels above this should be assessed. The degree of elevation of ALT and or AST in the clinical setting helps guide the evaluation. The evaluation of hepatocellular injury includes testing for viral hepatitis A, B, and C, assessment for nonalcoholic fatty liver disease and alcoholic liver disease, screening for hereditary hemochromatosis, autoimmune hepatitis, Wilson's disease, and alpha-1 antitrypsin deficiency. In addition, a history of prescribed and over-the-counter medicines should be sought. For the evaluation of an alkaline phosphatase elevation determined to be of hepatic origin, testing for primary biliary cholangitis and primary sclerosing cholangitis should be undertaken. Total bilirubin elevation can occur in either cholestatic or hepatocellular diseases. Elevated total serum bilirubin levels should be fractionated to direct and indirect bilirubin fractions and an elevated serum conjugated bilirubin implies hepatocellular disease or biliary obstruction in most settings. A liver biopsy may be considered when serologic testing and imaging fails to elucidate a diagnosis, to stage a condition, or when multiple diagnoses are possible.

3 Guideline [Wilson's disease: from clinical practice to guidelines]. 2014

Cao, Haixia / Chen, Yuanxen / Fan, Jiangao. · ·Zhonghua Gan Zang Bing Za Zhi · Pubmed #25350988.

ABSTRACT: -- No abstract --

4 Guideline EASL Clinical Practice Guidelines: Wilson's disease. 2012

Anonymous3090718. · ·J Hepatol · Pubmed #22340672.

ABSTRACT: This Clinical Practice Guideline (CPG) has been developed to assist physicians and other healthcare providers in the diagnosis and management of patients with Wilson's disease. The goal is to describe a number of generally accepted approaches for diagnosis, prevention, and treatment of Wilson's disease. Recommendations are based on a systematic literature review in the Medline (PubMed version), Embase (Dialog version), and the Cochrane Library databases using entries from 1966 to 2011. The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) system used in other EASL CPGs was used and set against the somewhat different grading system used in the AASLD guidelines (Table 1A and B). Unfortunately, there is not a single randomized controlled trial conducted in Wilson's disease which has an optimal design. Thus, it is impossible to assign a high or even a moderate quality of evidence to any of the questions dealt with in these guidelines. The evaluation is mostly based on large case series which have been reported within the last decades.

5 Editorial Challenges in molecular diagnosis of Wilson disease. 2020

Reeve, Janice Lv / Frayling, Ian M / Twomey, Patrick J. ·Clinical Chemistry, St. Vincent's University Hospital, Dublin, Ireland. · Clinical Chemistry, St. Vincent's University Hospital, Dublin, Ireland taptwomey@aol.com. · School of Medicine, University College Dublin, Dublin, Ireland. ·J Clin Pathol · Pubmed #32060076.

ABSTRACT: -- No abstract --

6 Editorial Highlights of the XXIII World Congress on Parkinson's Disease and Related Disorders. 2019

Moro, Elena / Fernandez, Hubert H. ·Division of Neurology, CHU of Grenoble, Grenoble Alpes University, INSERM U1216, Grenoble, France. Electronic address: elenamfmoro@gmail.com. · Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. ·Parkinsonism Relat Disord · Pubmed #31029231.

ABSTRACT: -- No abstract --

7 Editorial A Case for Not Going Global: "Americanization" of Diet Accelerates Hepatic Mitochondrial Injury in a Model of Wilson Disease. 2019

To, Uyen / Schilsky, Michael L. ·Departments of Medicine and Surgery, Divisions of Digestive Diseases and Transplant and Immunology, Yale University, New Haven, Connecticut. · Departments of Medicine and Surgery, Divisions of Digestive Diseases and Transplant and Immunology, Yale University, New Haven, Connecticut. Electronic address: michael.schilsky@yale.edu. ·Cell Mol Gastroenterol Hepatol · Pubmed #30707887.

ABSTRACT: -- No abstract --

8 Editorial Only the tip of the Iceberg? Role of ATP7B-exon skipping in Wilson disease. 2018

Rupp, Christian / Weiss, Karl Heinz. ·Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany. ·Liver Int · Pubmed #30133932.

ABSTRACT: -- No abstract --

9 Editorial Wilson's disease: the eponymous eminence of careful cognizance! 2018

Greydanus, Donald E / Merrick, Joav. ·Western Michigan University, Homer Stryker M.D. School of Medicine, Department of Pediatric and Adolescent Medicine, 1000 Oakland Drive, Kalamazoo, United States of America. · Department of Pediatrics, Mt Scopus Campus, Hadassah Hebrew University Medical Center and Director, National Institute of Child Health and Human Development, Jerusalem, Israel. ·Int J Adolesc Med Health · Pubmed #30068073.

ABSTRACT: -- No abstract --

10 Editorial Getting Better With Age and Time: A Look Back at the European Experience for Liver Transplantation for Pediatric Patients With Wilson's Disease. 2018

Schilsky, Michael L. ·Internal Medicine, Yale School of Medicine, New Haven, CT. ·Liver Transpl · Pubmed #30021047.

ABSTRACT: -- No abstract --

11 Editorial Pregnancy in Wilson disease. 2018

Rabiee, Atoosa / Hamilton, James P A. ·Johns Hopkins University School of Medicine, Baltimore, MD. ·Hepatology · Pubmed #29077220.

ABSTRACT: -- No abstract --

12 Editorial Wilson's disease: Prospective developments towards new therapies. 2017

Ranucci, Giusy / Polishchuck, Roman / Iorio, Raffaele. ·Giusy Ranucci, Raffaele Iorio, Department of Translational Medical Science, Section of Pediatric, University Federico II, 80131 Naples, Italy. ·World J Gastroenterol · Pubmed #28852304.

ABSTRACT: Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism, caused by mutations in the

13 Editorial Foreword. 2017

Aminoff, Michael J / Boller, François / Swaab, Dick F. · ·Handb Clin Neurol · Pubmed #28433116.

ABSTRACT: -- No abstract --

14 Editorial Preface. 2017

Członkowska, Anna / Schilsky, Michael L. · ·Handb Clin Neurol · Pubmed #28433115.

ABSTRACT: -- No abstract --

15 Editorial [Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease]. 2016

Bruguera, Miguel / Jara, Paloma / Berenguer, Marina / Mariño, Zoe. ·Servicio de Hepatología, Hospital Clínic, Barcelona, España. Electronic address: bruguera@clinic.cat. · Servicio de Hepatología Infantil, Hospital La Paz, Madrid, España. · Servicio de Digestivo, Hospital La Fe, Valencia, España. · Servicio de Hepatología, Hospital Clínic, Barcelona, España. ·Gastroenterol Hepatol · Pubmed #27496807.

ABSTRACT: -- No abstract --

16 Editorial Gene therapy of Wilson disease: A "golden" opportunity using rAAV on the 50th anniversary of the discovery of the virus. 2016

Roy-Chowdhury, Jayanta / Schilsky, Michael L. ·Department of Medicine (Gastroenterology and Liver Diseases), Department of Genetics and Marion Bessin Liver Research Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. Electronic address: Jayanta.Roy-Chowdhury@Einstein.YU.edu. · Division of Digestive Diseases and Transplantation and Immunology, Departments of Medicine and Surgery, Yale University, New Haven, CT 06520, USA. ·J Hepatol · Pubmed #26639392.

ABSTRACT: -- No abstract --

17 Editorial Maximizing the EMR's Educational Potential. 2015

Stern, Rachel J / Charlton, Blake. · ·JAMA Intern Med · Pubmed #26030418.

ABSTRACT: -- No abstract --

18 Editorial Costly choices for treating Wilson's disease. 2015

Schilsky, Michael L / Roberts, Eve A / Hahn, Sihoun / Askari, Frederick. ·Yale-New Haven Transplantation Center, Yale School of Medicine, New Haven, CT. ·Hepatology · Pubmed #25524500.

ABSTRACT: -- No abstract --

19 Editorial REM sleep behavior disorder, neurodegeneration and Wilson's disease. 2014

Limongi, João Carlos Papaterra. ·Departamento de Neurologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil. ·Arq Neuropsiquiatr · Pubmed #25252226.

ABSTRACT: -- No abstract --

20 Editorial The trientine crisis in Canada: a call to advocacy. 2014

Chandok, Natasha / Roberts, Eve A. · ·Can J Gastroenterol Hepatol · Pubmed #24729990.

ABSTRACT: -- No abstract --

21 Editorial Copper rewired. 2014

Anonymous570791. · ·Nature · Pubmed #24724184.

ABSTRACT: -- No abstract --

22 Editorial Quest for Life on MARS: mission incomplete. 2014

Jain, V / Dhawan, A. ·Paediatric Liver GI and Nutrition Centre, King's College London School of Medicine, King's College Hospital, London, UK. ·J Pediatr Gastroenterol Nutr · Pubmed #24464147.

ABSTRACT: -- No abstract --

23 Editorial Long-term outcome for Wilson disease: 85% good. 2014

Schilsky, Michael L. ·Section of Digestive Diseases and Transplantation and Immunology, Yale University Medical Center, New Haven, Connecticut. ·Clin Gastroenterol Hepatol · Pubmed #24246766.

ABSTRACT: -- No abstract --

24 Editorial [Foreword. Wilson's disease]. 2013

Woimant, F. ·Service de neurologie, Centre national de référence Maladie de Wilson, hôpital Lariboisière, AP-HP, 2, rue Ambroise-Paré, 75010 Paris, France. Electronic address: france.woimant@lrb.aphp.fr. ·Rev Neurol (Paris) · Pubmed #24239345.

ABSTRACT: -- No abstract --

25 Editorial Wilson's disease. 2013

Limongi, João Carlos Papaterra. · ·Arq Neuropsiquiatr · Pubmed #23982004.

ABSTRACT: -- No abstract --

Next